Jci_page_head_homepage_01 Jci_page_head_homepage_02
Marion Buyse, Françoise Berlioz, Sandra Guilmeau, Annick Tsocas, Thierry Voisin, Gabriel Péranzi, Didier Merlin, Marc Laburthe, Miguel J.M. Lewin, Claude Rozé, André Bado
Published in Volume 108, Issue 10
J Clin Invest. 2001; 108(10):1483–1494 doi:10.1172/JCI13219
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9

Leptin increases CFX absorption in vivo. (a) Evolution of plasma concentration of CFX during intrajejunal perfusion with 1 mM CFX (along with vehicle or 100 nM leptin) for 40 minutes. Results represent mean ± SEM in groups of six rats. *P < 0.05 and **P < 0.01 vs. vehicle. (b) Plasma concentration of CFX in the presence of 50 mM Gly-Gly competing for the dipeptide transporter in the jejunal lumen. Results represent mean ± SEM in groups of six rats. **P < 0.01 vs. control. ##P < 0.01 vs. leptin alone.